
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
Expected to be Effective as of Commencement of Trading on August 15, 2025 ReShape Lifesciences has announced that its shareholders have approved all the necessary
Expected to be Effective as of Commencement of Trading on August 15, 2025 ReShape Lifesciences has announced that its shareholders have approved all the necessary
Fuel up with free Health Tech Insights